Drug not used in the management of PPH
**Core Concept**
Postpartum hemorrhage (PPH) is a leading cause of maternal mortality worldwide, characterized by excessive bleeding following childbirth. Effective management of PPH involves the use of uterotonic agents to induce uterine contractions and control bleeding.
**Why the Correct Answer is Right**
The management of PPH typically involves the use of uterotonic agents such as oxytocin, carboprost tromethamine (Hemabate), and methylergonovine (Methergine). Oxytocin is a synthetic hormone that stimulates uterine contractions, while carboprost and methylergonovine are prostaglandin analogs and ergot alkaloids, respectively, that also induce uterine contractions. These agents are all commonly used in the management of PPH.
**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because oxytocin is a commonly used uterotonic agent in the management of PPH.
**Option B:**
This option is incorrect because carboprost tromethamine (Hemabate) is a prostaglandin analog used to induce uterine contractions in the management of PPH.
**Option C:**
This option is incorrect because methylergonovine (Methergine) is an ergot alkaloid used to induce uterine contractions in the management of PPH.
**Clinical Pearl / High-Yield Fact**
In the management of PPH, the use of uterotonic agents is typically initiated with oxytocin, followed by the use of prostaglandin analogs or ergot alkaloids if necessary.
**Correct Answer:** A. Oxytocin